nodes	percent_of_prediction	percent_of_DWPC	metapath
Meprobamate—CYP2E1—Fingolimod—multiple sclerosis	0.212	0.284	CbGbCtD
Meprobamate—CYP2E1—Mitoxantrone—multiple sclerosis	0.0996	0.134	CbGbCtD
Meprobamate—ABCB1—Methylprednisolone—multiple sclerosis	0.0691	0.0927	CbGbCtD
Meprobamate—CYP2C19—Prednisone—multiple sclerosis	0.0519	0.0696	CbGbCtD
Meprobamate—CYP2E1—Dexamethasone—multiple sclerosis	0.0517	0.0693	CbGbCtD
Meprobamate—ABCB1—Mitoxantrone—multiple sclerosis	0.0504	0.0676	CbGbCtD
Meprobamate—ABCB1—Betamethasone—multiple sclerosis	0.0449	0.0603	CbGbCtD
Meprobamate—ABCB1—Prednisolone—multiple sclerosis	0.0443	0.0595	CbGbCtD
Meprobamate—ABCB1—Prednisone—multiple sclerosis	0.0418	0.0562	CbGbCtD
Meprobamate—CYP2C19—Dexamethasone—multiple sclerosis	0.0324	0.0435	CbGbCtD
Meprobamate—ABCB1—Dexamethasone—multiple sclerosis	0.0261	0.0351	CbGbCtD
Meprobamate—ABCB1—Methotrexate—multiple sclerosis	0.021	0.0282	CbGbCtD
Meprobamate—Hypotensive—Betamethasone—multiple sclerosis	0.00371	0.0194	CcSEcCtD
Meprobamate—Hypotensive—Dexamethasone—multiple sclerosis	0.00371	0.0194	CcSEcCtD
Meprobamate—Petechiae—Cladribine—multiple sclerosis	0.00366	0.0191	CcSEcCtD
Meprobamate—GABRA6—brainstem—multiple sclerosis	0.00323	0.0509	CbGeAlD
Meprobamate—Aplastic anaemia—Cladribine—multiple sclerosis	0.00283	0.0148	CcSEcCtD
Meprobamate—Anuria—Methotrexate—multiple sclerosis	0.00282	0.0147	CcSEcCtD
Meprobamate—Ecchymosis—Cladribine—multiple sclerosis	0.00272	0.0142	CcSEcCtD
Meprobamate—Vascular purpura—Cladribine—multiple sclerosis	0.00244	0.0128	CcSEcCtD
Meprobamate—Petechiae—Mitoxantrone—multiple sclerosis	0.00241	0.0126	CcSEcCtD
Meprobamate—Aplastic anaemia—Azathioprine—multiple sclerosis	0.0023	0.012	CcSEcCtD
Meprobamate—Purpura—Cladribine—multiple sclerosis	0.00227	0.0119	CcSEcCtD
Meprobamate—GABRA2—brainstem—multiple sclerosis	0.00217	0.0343	CbGeAlD
Meprobamate—GABRA1—brainstem—multiple sclerosis	0.0021	0.0331	CbGeAlD
Meprobamate—Leukopenia—Fingolimod—multiple sclerosis	0.00208	0.0109	CcSEcCtD
Meprobamate—Ataxia—Cladribine—multiple sclerosis	0.00206	0.0107	CcSEcCtD
Meprobamate—Palpitations—Fingolimod—multiple sclerosis	0.00205	0.0107	CcSEcCtD
Meprobamate—Petechiae—Prednisolone—multiple sclerosis	0.00197	0.0103	CcSEcCtD
Meprobamate—Eosinophilia—Cladribine—multiple sclerosis	0.00187	0.00977	CcSEcCtD
Meprobamate—Petechiae—Triamcinolone—multiple sclerosis	0.00182	0.00948	CcSEcCtD
Meprobamate—Petechiae—Methylprednisolone—multiple sclerosis	0.00181	0.00946	CcSEcCtD
Meprobamate—Ecchymosis—Mitoxantrone—multiple sclerosis	0.00179	0.00935	CcSEcCtD
Meprobamate—Hypotension—Fingolimod—multiple sclerosis	0.00177	0.00925	CcSEcCtD
Meprobamate—Paraesthesia—Fingolimod—multiple sclerosis	0.0017	0.00889	CcSEcCtD
Meprobamate—GABRA6—nervous system—multiple sclerosis	0.00169	0.0267	CbGeAlD
Meprobamate—Stevens-Johnson syndrome—Cladribine—multiple sclerosis	0.00167	0.00873	CcSEcCtD
Meprobamate—GABRG2—medulla oblongata—multiple sclerosis	0.00166	0.0262	CbGeAlD
Meprobamate—Petechiae—Dexamethasone—multiple sclerosis	0.00165	0.00861	CcSEcCtD
Meprobamate—Petechiae—Betamethasone—multiple sclerosis	0.00165	0.00861	CcSEcCtD
Meprobamate—GABRA5—nervous system—multiple sclerosis	0.00164	0.0259	CbGeAlD
Meprobamate—GABRA6—central nervous system—multiple sclerosis	0.00163	0.0257	CbGeAlD
Meprobamate—GABRA6—cerebellum—multiple sclerosis	0.00159	0.0251	CbGeAlD
Meprobamate—GABRA5—central nervous system—multiple sclerosis	0.00158	0.0249	CbGeAlD
Meprobamate—GABRA3—nervous system—multiple sclerosis	0.00153	0.0241	CbGeAlD
Meprobamate—GABRG2—midbrain—multiple sclerosis	0.00152	0.0239	CbGeAlD
Meprobamate—Oedema peripheral—Cladribine—multiple sclerosis	0.00149	0.00778	CcSEcCtD
Meprobamate—GABRA4—nervous system—multiple sclerosis	0.00149	0.0235	CbGeAlD
Meprobamate—GABRG2—spinal cord—multiple sclerosis	0.00148	0.0233	CbGeAlD
Meprobamate—GABRA3—central nervous system—multiple sclerosis	0.00147	0.0232	CbGeAlD
Meprobamate—Ecchymosis—Prednisolone—multiple sclerosis	0.00147	0.00767	CcSEcCtD
Meprobamate—GABRA1—medulla oblongata—multiple sclerosis	0.00146	0.0231	CbGeAlD
Meprobamate—Petechiae—Prednisone—multiple sclerosis	0.00143	0.00749	CcSEcCtD
Meprobamate—GABRA4—central nervous system—multiple sclerosis	0.00143	0.0226	CbGeAlD
Meprobamate—Erythema multiforme—Cladribine—multiple sclerosis	0.00143	0.00747	CcSEcCtD
Meprobamate—GABRA4—cerebellum—multiple sclerosis	0.0014	0.0221	CbGeAlD
Meprobamate—Euphoric mood—Prednisolone—multiple sclerosis	0.0014	0.00729	CcSEcCtD
Meprobamate—Asthenia—Fingolimod—multiple sclerosis	0.00136	0.00711	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Azathioprine—multiple sclerosis	0.00136	0.0071	CcSEcCtD
Meprobamate—Chills—Cladribine—multiple sclerosis	0.00136	0.00709	CcSEcCtD
Meprobamate—Arrhythmia—Cladribine—multiple sclerosis	0.00135	0.00706	CcSEcCtD
Meprobamate—Ecchymosis—Triamcinolone—multiple sclerosis	0.00135	0.00706	CcSEcCtD
Meprobamate—Ecchymosis—Methylprednisolone—multiple sclerosis	0.00135	0.00704	CcSEcCtD
Meprobamate—Pruritus—Fingolimod—multiple sclerosis	0.00134	0.00701	CcSEcCtD
Meprobamate—GABRA1—midbrain—multiple sclerosis	0.00134	0.0211	CbGeAlD
Meprobamate—GABRA1—spinal cord—multiple sclerosis	0.00131	0.0206	CbGeAlD
Meprobamate—Diarrhoea—Fingolimod—multiple sclerosis	0.0013	0.00678	CcSEcCtD
Meprobamate—GABRA6—brain—multiple sclerosis	0.00129	0.0204	CbGeAlD
Meprobamate—Euphoric mood—Triamcinolone—multiple sclerosis	0.00128	0.0067	CcSEcCtD
Meprobamate—Euphoric mood—Methylprednisolone—multiple sclerosis	0.00128	0.00669	CcSEcCtD
Meprobamate—Agranulocytosis—Azathioprine—multiple sclerosis	0.00128	0.00668	CcSEcCtD
Meprobamate—GABRB3—medulla oblongata—multiple sclerosis	0.00127	0.0201	CbGeAlD
Meprobamate—GABRA5—brain—multiple sclerosis	0.00125	0.0198	CbGeAlD
Meprobamate—Dizziness—Fingolimod—multiple sclerosis	0.00125	0.00655	CcSEcCtD
Meprobamate—GABRG2—nervous system—multiple sclerosis	0.00125	0.0197	CbGeAlD
Meprobamate—Dermatitis bullous—Prednisolone—multiple sclerosis	0.00123	0.00644	CcSEcCtD
Meprobamate—Ecchymosis—Dexamethasone—multiple sclerosis	0.00123	0.0064	CcSEcCtD
Meprobamate—Ecchymosis—Betamethasone—multiple sclerosis	0.00123	0.0064	CcSEcCtD
Meprobamate—Vascular purpura—Triamcinolone—multiple sclerosis	0.00121	0.00633	CcSEcCtD
Meprobamate—GABRG2—central nervous system—multiple sclerosis	0.0012	0.0189	CbGeAlD
Meprobamate—Petechiae—Methotrexate—multiple sclerosis	0.0012	0.00626	CcSEcCtD
Meprobamate—Headache—Fingolimod—multiple sclerosis	0.00119	0.0062	CcSEcCtD
Meprobamate—GABRG2—cerebellum—multiple sclerosis	0.00117	0.0185	CbGeAlD
Meprobamate—GABRA3—brain—multiple sclerosis	0.00117	0.0184	CbGeAlD
Meprobamate—Euphoric mood—Dexamethasone—multiple sclerosis	0.00116	0.00608	CcSEcCtD
Meprobamate—Euphoric mood—Betamethasone—multiple sclerosis	0.00116	0.00608	CcSEcCtD
Meprobamate—GABRB3—midbrain—multiple sclerosis	0.00116	0.0184	CbGeAlD
Meprobamate—Erythema multiforme—Azathioprine—multiple sclerosis	0.00116	0.00607	CcSEcCtD
Meprobamate—GABRA4—brain—multiple sclerosis	0.00114	0.018	CbGeAlD
Meprobamate—GABRA2—nervous system—multiple sclerosis	0.00114	0.018	CbGeAlD
Meprobamate—GABRB3—spinal cord—multiple sclerosis	0.00114	0.0179	CbGeAlD
Meprobamate—Dermatitis bullous—Triamcinolone—multiple sclerosis	0.00113	0.00593	CcSEcCtD
Meprobamate—Purpura—Triamcinolone—multiple sclerosis	0.00112	0.00588	CcSEcCtD
Meprobamate—Drowsiness—Mitoxantrone—multiple sclerosis	0.00111	0.00579	CcSEcCtD
Meprobamate—Chills—Azathioprine—multiple sclerosis	0.0011	0.00577	CcSEcCtD
Meprobamate—GABRA1—nervous system—multiple sclerosis	0.0011	0.0174	CbGeAlD
Meprobamate—Arrhythmia—Azathioprine—multiple sclerosis	0.0011	0.00574	CcSEcCtD
Meprobamate—GABRA2—central nervous system—multiple sclerosis	0.0011	0.0173	CbGeAlD
Meprobamate—Stomatitis—Mitoxantrone—multiple sclerosis	0.00108	0.00564	CcSEcCtD
Meprobamate—GABRA2—cerebellum—multiple sclerosis	0.00107	0.0169	CbGeAlD
Meprobamate—Oliguria—Methotrexate—multiple sclerosis	0.00107	0.00559	CcSEcCtD
Meprobamate—Ecchymosis—Prednisone—multiple sclerosis	0.00107	0.00557	CcSEcCtD
Meprobamate—GABRA1—central nervous system—multiple sclerosis	0.00106	0.0167	CbGeAlD
Meprobamate—Tachycardia—Cladribine—multiple sclerosis	0.00105	0.00548	CcSEcCtD
Meprobamate—Dysarthria—Methotrexate—multiple sclerosis	0.00104	0.00545	CcSEcCtD
Meprobamate—GABRA1—cerebellum—multiple sclerosis	0.00104	0.0163	CbGeAlD
Meprobamate—Agranulocytosis—Mitoxantrone—multiple sclerosis	0.00103	0.0054	CcSEcCtD
Meprobamate—Dermatitis bullous—Betamethasone—multiple sclerosis	0.00103	0.00538	CcSEcCtD
Meprobamate—Dermatitis bullous—Dexamethasone—multiple sclerosis	0.00103	0.00538	CcSEcCtD
Meprobamate—Euphoric mood—Prednisone—multiple sclerosis	0.00101	0.0053	CcSEcCtD
Meprobamate—Hypotension—Cladribine—multiple sclerosis	0.001	0.00525	CcSEcCtD
Meprobamate—Paraesthesia—Cladribine—multiple sclerosis	0.000965	0.00504	CcSEcCtD
Meprobamate—Leukopenia—Azathioprine—multiple sclerosis	0.000958	0.00501	CcSEcCtD
Meprobamate—Vascular purpura—Prednisone—multiple sclerosis	0.000958	0.005	CcSEcCtD
Meprobamate—GABRB3—nervous system—multiple sclerosis	0.000957	0.0151	CbGeAlD
Meprobamate—Somnolence—Cladribine—multiple sclerosis	0.000955	0.00499	CcSEcCtD
Meprobamate—GABRG2—brain—multiple sclerosis	0.000952	0.015	CbGeAlD
Meprobamate—Aplastic anaemia—Methotrexate—multiple sclerosis	0.000926	0.00484	CcSEcCtD
Meprobamate—GABRB3—central nervous system—multiple sclerosis	0.000921	0.0145	CbGeAlD
Meprobamate—Bronchospasm—Methylprednisolone—multiple sclerosis	0.00092	0.0048	CcSEcCtD
Meprobamate—GABRB3—cerebellum—multiple sclerosis	0.0009	0.0142	CbGeAlD
Meprobamate—Chills—Mitoxantrone—multiple sclerosis	0.000892	0.00466	CcSEcCtD
Meprobamate—Ecchymosis—Methotrexate—multiple sclerosis	0.000892	0.00466	CcSEcCtD
Meprobamate—Purpura—Prednisone—multiple sclerosis	0.000889	0.00464	CcSEcCtD
Meprobamate—Arrhythmia—Mitoxantrone—multiple sclerosis	0.000888	0.00464	CcSEcCtD
Meprobamate—GABRA2—brain—multiple sclerosis	0.00087	0.0137	CbGeAlD
Meprobamate—Body temperature increased—Cladribine—multiple sclerosis	0.000849	0.00444	CcSEcCtD
Meprobamate—GABRA1—brain—multiple sclerosis	0.000841	0.0133	CbGeAlD
Meprobamate—Lymphadenopathy—Methotrexate—multiple sclerosis	0.000839	0.00438	CcSEcCtD
Meprobamate—Hypotension—Azathioprine—multiple sclerosis	0.000816	0.00427	CcSEcCtD
Meprobamate—CYP2E1—medulla oblongata—multiple sclerosis	0.00081	0.0128	CbGeAlD
Meprobamate—Hypersensitivity—Cladribine—multiple sclerosis	0.000792	0.00414	CcSEcCtD
Meprobamate—Leukopenia—Mitoxantrone—multiple sclerosis	0.000775	0.00405	CcSEcCtD
Meprobamate—Asthenia—Cladribine—multiple sclerosis	0.000771	0.00403	CcSEcCtD
Meprobamate—Pruritus—Cladribine—multiple sclerosis	0.00076	0.00397	CcSEcCtD
Meprobamate—Dermatitis exfoliative—Methotrexate—multiple sclerosis	0.000759	0.00396	CcSEcCtD
Meprobamate—Diarrhoea—Cladribine—multiple sclerosis	0.000735	0.00384	CcSEcCtD
Meprobamate—GABRB3—brain—multiple sclerosis	0.000731	0.0115	CbGeAlD
Meprobamate—Arrhythmia—Prednisolone—multiple sclerosis	0.000729	0.00381	CcSEcCtD
Meprobamate—CYP2E1—spinal cord—multiple sclerosis	0.000722	0.0114	CbGeAlD
Meprobamate—Dizziness—Cladribine—multiple sclerosis	0.000711	0.00371	CcSEcCtD
Meprobamate—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000706	0.00369	CcSEcCtD
Meprobamate—Shock—Mitoxantrone—multiple sclerosis	0.000695	0.00363	CcSEcCtD
Meprobamate—Body temperature increased—Azathioprine—multiple sclerosis	0.000691	0.00361	CcSEcCtD
Meprobamate—Tachycardia—Mitoxantrone—multiple sclerosis	0.000689	0.0036	CcSEcCtD
Meprobamate—Vomiting—Cladribine—multiple sclerosis	0.000683	0.00357	CcSEcCtD
Meprobamate—Dermatitis—Cladribine—multiple sclerosis	0.000677	0.00354	CcSEcCtD
Meprobamate—Ataxia—Methotrexate—multiple sclerosis	0.000673	0.00352	CcSEcCtD
Meprobamate—Headache—Cladribine—multiple sclerosis	0.000673	0.00352	CcSEcCtD
Meprobamate—Arrhythmia—Triamcinolone—multiple sclerosis	0.00067	0.0035	CcSEcCtD
Meprobamate—Arrhythmia—Methylprednisolone—multiple sclerosis	0.000669	0.00349	CcSEcCtD
Meprobamate—Hypotension—Mitoxantrone—multiple sclerosis	0.00066	0.00345	CcSEcCtD
Meprobamate—Angioedema—Prednisolone—multiple sclerosis	0.000649	0.00339	CcSEcCtD
Meprobamate—Hypersensitivity—Azathioprine—multiple sclerosis	0.000644	0.00336	CcSEcCtD
Meprobamate—ABCB1—retina—multiple sclerosis	0.000638	0.0101	CbGeAlD
Meprobamate—Nausea—Cladribine—multiple sclerosis	0.000638	0.00333	CcSEcCtD
Meprobamate—Vertigo—Prednisolone—multiple sclerosis	0.000638	0.00333	CcSEcCtD
Meprobamate—Syncope—Prednisolone—multiple sclerosis	0.000637	0.00333	CcSEcCtD
Meprobamate—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000634	0.00331	CcSEcCtD
Meprobamate—Somnolence—Mitoxantrone—multiple sclerosis	0.000628	0.00328	CcSEcCtD
Meprobamate—Loss of consciousness—Prednisolone—multiple sclerosis	0.000624	0.00326	CcSEcCtD
Meprobamate—Eosinophilia—Methotrexate—multiple sclerosis	0.000613	0.0032	CcSEcCtD
Meprobamate—CYP2E1—nervous system—multiple sclerosis	0.000609	0.0096	CbGeAlD
Meprobamate—Arrhythmia—Betamethasone—multiple sclerosis	0.000608	0.00318	CcSEcCtD
Meprobamate—Arrhythmia—Dexamethasone—multiple sclerosis	0.000608	0.00318	CcSEcCtD
Meprobamate—Diarrhoea—Azathioprine—multiple sclerosis	0.000598	0.00312	CcSEcCtD
Meprobamate—Angioedema—Triamcinolone—multiple sclerosis	0.000597	0.00312	CcSEcCtD
Meprobamate—Angioedema—Methylprednisolone—multiple sclerosis	0.000595	0.00311	CcSEcCtD
Meprobamate—Vertigo—Triamcinolone—multiple sclerosis	0.000587	0.00306	CcSEcCtD
Meprobamate—CYP2E1—central nervous system—multiple sclerosis	0.000586	0.00924	CbGeAlD
Meprobamate—Syncope—Triamcinolone—multiple sclerosis	0.000586	0.00306	CcSEcCtD
Meprobamate—Vertigo—Methylprednisolone—multiple sclerosis	0.000585	0.00306	CcSEcCtD
Meprobamate—Syncope—Methylprednisolone—multiple sclerosis	0.000584	0.00305	CcSEcCtD
Meprobamate—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000579	0.00303	CcSEcCtD
Meprobamate—Dizziness—Azathioprine—multiple sclerosis	0.000578	0.00302	CcSEcCtD
Meprobamate—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000574	0.003	CcSEcCtD
Meprobamate—CYP2E1—cerebellum—multiple sclerosis	0.000573	0.00903	CbGeAlD
Meprobamate—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000573	0.00299	CcSEcCtD
Meprobamate—Shock—Prednisolone—multiple sclerosis	0.00057	0.00298	CcSEcCtD
Meprobamate—Tachycardia—Prednisolone—multiple sclerosis	0.000566	0.00295	CcSEcCtD
Meprobamate—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000558	0.00292	CcSEcCtD
Meprobamate—Vomiting—Azathioprine—multiple sclerosis	0.000556	0.0029	CcSEcCtD
Meprobamate—Drowsiness—Methotrexate—multiple sclerosis	0.000552	0.00288	CcSEcCtD
Meprobamate—Dermatitis—Azathioprine—multiple sclerosis	0.00055	0.00288	CcSEcCtD
Meprobamate—Headache—Azathioprine—multiple sclerosis	0.000547	0.00286	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000547	0.00286	CcSEcCtD
Meprobamate—Angioedema—Betamethasone—multiple sclerosis	0.000541	0.00283	CcSEcCtD
Meprobamate—Angioedema—Dexamethasone—multiple sclerosis	0.000541	0.00283	CcSEcCtD
Meprobamate—Stomatitis—Methotrexate—multiple sclerosis	0.000538	0.00281	CcSEcCtD
Meprobamate—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000533	0.00278	CcSEcCtD
Meprobamate—Vertigo—Dexamethasone—multiple sclerosis	0.000532	0.00278	CcSEcCtD
Meprobamate—Vertigo—Betamethasone—multiple sclerosis	0.000532	0.00278	CcSEcCtD
Meprobamate—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000532	0.00278	CcSEcCtD
Meprobamate—Syncope—Dexamethasone—multiple sclerosis	0.000531	0.00278	CcSEcCtD
Meprobamate—Syncope—Betamethasone—multiple sclerosis	0.000531	0.00278	CcSEcCtD
Meprobamate—Arrhythmia—Prednisone—multiple sclerosis	0.000529	0.00277	CcSEcCtD
Meprobamate—Shock—Triamcinolone—multiple sclerosis	0.000524	0.00274	CcSEcCtD
Meprobamate—Shock—Methylprednisolone—multiple sclerosis	0.000523	0.00273	CcSEcCtD
Meprobamate—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000521	0.00272	CcSEcCtD
Meprobamate—Loss of consciousness—Betamethasone—multiple sclerosis	0.000521	0.00272	CcSEcCtD
Meprobamate—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00052	0.00272	CcSEcCtD
Meprobamate—Paraesthesia—Prednisolone—multiple sclerosis	0.00052	0.00272	CcSEcCtD
Meprobamate—Tachycardia—Triamcinolone—multiple sclerosis	0.00052	0.00272	CcSEcCtD
Meprobamate—Nausea—Azathioprine—multiple sclerosis	0.000519	0.00271	CcSEcCtD
Meprobamate—Tachycardia—Methylprednisolone—multiple sclerosis	0.000519	0.00271	CcSEcCtD
Meprobamate—Agranulocytosis—Methotrexate—multiple sclerosis	0.000515	0.00269	CcSEcCtD
Meprobamate—Asthenia—Mitoxantrone—multiple sclerosis	0.000507	0.00265	CcSEcCtD
Meprobamate—Hypotension—Methylprednisolone—multiple sclerosis	0.000497	0.0026	CcSEcCtD
Meprobamate—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000483	0.00253	CcSEcCtD
Meprobamate—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000483	0.00253	CcSEcCtD
Meprobamate—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000483	0.00252	CcSEcCtD
Meprobamate—Paraesthesia—Triamcinolone—multiple sclerosis	0.000478	0.0025	CcSEcCtD
Meprobamate—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000477	0.00249	CcSEcCtD
Meprobamate—Shock—Betamethasone—multiple sclerosis	0.000476	0.00249	CcSEcCtD
Meprobamate—Shock—Dexamethasone—multiple sclerosis	0.000476	0.00249	CcSEcCtD
Meprobamate—Agitation—Prednisone—multiple sclerosis	0.000474	0.00248	CcSEcCtD
Meprobamate—Tachycardia—Betamethasone—multiple sclerosis	0.000472	0.00247	CcSEcCtD
Meprobamate—Tachycardia—Dexamethasone—multiple sclerosis	0.000472	0.00247	CcSEcCtD
Meprobamate—Angioedema—Prednisone—multiple sclerosis	0.000471	0.00246	CcSEcCtD
Meprobamate—Erythema multiforme—Methotrexate—multiple sclerosis	0.000468	0.00245	CcSEcCtD
Meprobamate—CYP2E1—brain—multiple sclerosis	0.000465	0.00734	CbGeAlD
Meprobamate—Vertigo—Prednisone—multiple sclerosis	0.000464	0.00242	CcSEcCtD
Meprobamate—Syncope—Prednisone—multiple sclerosis	0.000463	0.00242	CcSEcCtD
Meprobamate—ABCB1—medulla oblongata—multiple sclerosis	0.000461	0.00728	CbGeAlD
Meprobamate—Loss of consciousness—Prednisone—multiple sclerosis	0.000453	0.00237	CcSEcCtD
Meprobamate—Hypotension—Dexamethasone—multiple sclerosis	0.000452	0.00236	CcSEcCtD
Meprobamate—Hypotension—Betamethasone—multiple sclerosis	0.000452	0.00236	CcSEcCtD
Meprobamate—Vomiting—Mitoxantrone—multiple sclerosis	0.000449	0.00235	CcSEcCtD
Meprobamate—Dermatitis—Mitoxantrone—multiple sclerosis	0.000445	0.00232	CcSEcCtD
Meprobamate—Chills—Methotrexate—multiple sclerosis	0.000444	0.00232	CcSEcCtD
Meprobamate—Headache—Mitoxantrone—multiple sclerosis	0.000442	0.00231	CcSEcCtD
Meprobamate—Paraesthesia—Betamethasone—multiple sclerosis	0.000434	0.00227	CcSEcCtD
Meprobamate—Paraesthesia—Dexamethasone—multiple sclerosis	0.000434	0.00227	CcSEcCtD
Meprobamate—Hypersensitivity—Prednisolone—multiple sclerosis	0.000427	0.00223	CcSEcCtD
Meprobamate—ABCB1—midbrain—multiple sclerosis	0.000422	0.00665	CbGeAlD
Meprobamate—Body temperature increased—Triamcinolone—multiple sclerosis	0.000421	0.0022	CcSEcCtD
Meprobamate—Anaphylactic shock—Prednisone—multiple sclerosis	0.000421	0.0022	CcSEcCtD
Meprobamate—Nausea—Mitoxantrone—multiple sclerosis	0.00042	0.00219	CcSEcCtD
Meprobamate—Shock—Prednisone—multiple sclerosis	0.000414	0.00216	CcSEcCtD
Meprobamate—ABCB1—spinal cord—multiple sclerosis	0.000411	0.00649	CbGeAlD
Meprobamate—Tachycardia—Prednisone—multiple sclerosis	0.000411	0.00215	CcSEcCtD
Meprobamate—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000393	0.00205	CcSEcCtD
Meprobamate—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000392	0.00205	CcSEcCtD
Meprobamate—Vertigo—Methotrexate—multiple sclerosis	0.000387	0.00202	CcSEcCtD
Meprobamate—Leukopenia—Methotrexate—multiple sclerosis	0.000386	0.00202	CcSEcCtD
Meprobamate—Dizziness—Prednisolone—multiple sclerosis	0.000383	0.002	CcSEcCtD
Meprobamate—Asthenia—Triamcinolone—multiple sclerosis	0.000382	0.002	CcSEcCtD
Meprobamate—Body temperature increased—Betamethasone—multiple sclerosis	0.000382	0.002	CcSEcCtD
Meprobamate—Body temperature increased—Dexamethasone—multiple sclerosis	0.000382	0.002	CcSEcCtD
Meprobamate—Asthenia—Methylprednisolone—multiple sclerosis	0.000381	0.00199	CcSEcCtD
Meprobamate—Paraesthesia—Prednisone—multiple sclerosis	0.000378	0.00198	CcSEcCtD
Meprobamate—Pruritus—Triamcinolone—multiple sclerosis	0.000377	0.00197	CcSEcCtD
Meprobamate—Pruritus—Methylprednisolone—multiple sclerosis	0.000376	0.00197	CcSEcCtD
Meprobamate—Dermatitis—Prednisolone—multiple sclerosis	0.000365	0.00191	CcSEcCtD
Meprobamate—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000364	0.0019	CcSEcCtD
Meprobamate—Headache—Prednisolone—multiple sclerosis	0.000363	0.0019	CcSEcCtD
Meprobamate—Dizziness—Triamcinolone—multiple sclerosis	0.000352	0.00184	CcSEcCtD
Meprobamate—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000352	0.00184	CcSEcCtD
Meprobamate—Dizziness—Methylprednisolone—multiple sclerosis	0.000352	0.00184	CcSEcCtD
Meprobamate—Asthenia—Betamethasone—multiple sclerosis	0.000347	0.00181	CcSEcCtD
Meprobamate—Asthenia—Dexamethasone—multiple sclerosis	0.000347	0.00181	CcSEcCtD
Meprobamate—ABCB1—nervous system—multiple sclerosis	0.000347	0.00547	CbGeAlD
Meprobamate—Nausea—Prednisolone—multiple sclerosis	0.000344	0.0018	CcSEcCtD
Meprobamate—Pruritus—Dexamethasone—multiple sclerosis	0.000342	0.00179	CcSEcCtD
Meprobamate—Pruritus—Betamethasone—multiple sclerosis	0.000342	0.00179	CcSEcCtD
Meprobamate—Vomiting—Triamcinolone—multiple sclerosis	0.000339	0.00177	CcSEcCtD
Meprobamate—Vomiting—Methylprednisolone—multiple sclerosis	0.000338	0.00177	CcSEcCtD
Meprobamate—Dermatitis—Triamcinolone—multiple sclerosis	0.000336	0.00175	CcSEcCtD
Meprobamate—Dermatitis—Methylprednisolone—multiple sclerosis	0.000335	0.00175	CcSEcCtD
Meprobamate—Headache—Triamcinolone—multiple sclerosis	0.000334	0.00174	CcSEcCtD
Meprobamate—ABCB1—central nervous system—multiple sclerosis	0.000334	0.00526	CbGeAlD
Meprobamate—Headache—Methylprednisolone—multiple sclerosis	0.000333	0.00174	CcSEcCtD
Meprobamate—Body temperature increased—Prednisone—multiple sclerosis	0.000333	0.00174	CcSEcCtD
Meprobamate—Diarrhoea—Dexamethasone—multiple sclerosis	0.000331	0.00173	CcSEcCtD
Meprobamate—Diarrhoea—Betamethasone—multiple sclerosis	0.000331	0.00173	CcSEcCtD
Meprobamate—Hypotension—Methotrexate—multiple sclerosis	0.000329	0.00172	CcSEcCtD
Meprobamate—ABCB1—cerebellum—multiple sclerosis	0.000326	0.00515	CbGeAlD
Meprobamate—Dizziness—Betamethasone—multiple sclerosis	0.00032	0.00167	CcSEcCtD
Meprobamate—Dizziness—Dexamethasone—multiple sclerosis	0.00032	0.00167	CcSEcCtD
Meprobamate—Nausea—Triamcinolone—multiple sclerosis	0.000317	0.00165	CcSEcCtD
Meprobamate—Paraesthesia—Methotrexate—multiple sclerosis	0.000316	0.00165	CcSEcCtD
Meprobamate—Nausea—Methylprednisolone—multiple sclerosis	0.000316	0.00165	CcSEcCtD
Meprobamate—Somnolence—Methotrexate—multiple sclerosis	0.000313	0.00163	CcSEcCtD
Meprobamate—Hypersensitivity—Prednisone—multiple sclerosis	0.00031	0.00162	CcSEcCtD
Meprobamate—Vomiting—Dexamethasone—multiple sclerosis	0.000307	0.00161	CcSEcCtD
Meprobamate—Vomiting—Betamethasone—multiple sclerosis	0.000307	0.00161	CcSEcCtD
Meprobamate—Dermatitis—Betamethasone—multiple sclerosis	0.000305	0.00159	CcSEcCtD
Meprobamate—Dermatitis—Dexamethasone—multiple sclerosis	0.000305	0.00159	CcSEcCtD
Meprobamate—Headache—Betamethasone—multiple sclerosis	0.000303	0.00158	CcSEcCtD
Meprobamate—Headache—Dexamethasone—multiple sclerosis	0.000303	0.00158	CcSEcCtD
Meprobamate—Asthenia—Prednisone—multiple sclerosis	0.000302	0.00158	CcSEcCtD
Meprobamate—Pruritus—Prednisone—multiple sclerosis	0.000298	0.00156	CcSEcCtD
Meprobamate—Diarrhoea—Prednisone—multiple sclerosis	0.000288	0.00151	CcSEcCtD
Meprobamate—Nausea—Dexamethasone—multiple sclerosis	0.000287	0.0015	CcSEcCtD
Meprobamate—Nausea—Betamethasone—multiple sclerosis	0.000287	0.0015	CcSEcCtD
Meprobamate—Dizziness—Prednisone—multiple sclerosis	0.000278	0.00145	CcSEcCtD
Meprobamate—Body temperature increased—Methotrexate—multiple sclerosis	0.000278	0.00145	CcSEcCtD
Meprobamate—Vomiting—Prednisone—multiple sclerosis	0.000268	0.0014	CcSEcCtD
Meprobamate—Dermatitis—Prednisone—multiple sclerosis	0.000265	0.00139	CcSEcCtD
Meprobamate—ABCB1—brain—multiple sclerosis	0.000265	0.00418	CbGeAlD
Meprobamate—Headache—Prednisone—multiple sclerosis	0.000264	0.00138	CcSEcCtD
Meprobamate—Hypersensitivity—Methotrexate—multiple sclerosis	0.000259	0.00135	CcSEcCtD
Meprobamate—Asthenia—Methotrexate—multiple sclerosis	0.000252	0.00132	CcSEcCtD
Meprobamate—Nausea—Prednisone—multiple sclerosis	0.00025	0.00131	CcSEcCtD
Meprobamate—Pruritus—Methotrexate—multiple sclerosis	0.000249	0.0013	CcSEcCtD
Meprobamate—Diarrhoea—Methotrexate—multiple sclerosis	0.000241	0.00126	CcSEcCtD
Meprobamate—Dizziness—Methotrexate—multiple sclerosis	0.000233	0.00122	CcSEcCtD
Meprobamate—Vomiting—Methotrexate—multiple sclerosis	0.000224	0.00117	CcSEcCtD
Meprobamate—Dermatitis—Methotrexate—multiple sclerosis	0.000222	0.00116	CcSEcCtD
Meprobamate—Headache—Methotrexate—multiple sclerosis	0.00022	0.00115	CcSEcCtD
Meprobamate—Nausea—Methotrexate—multiple sclerosis	0.000209	0.00109	CcSEcCtD
